Key terms
About NSPR
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NSPR news
Apr 02
9:22am ET
InspireMD Boosts Executive Severance Benefits Ahead of Potential Takeover
Mar 26
8:12am ET
InspireMD to Present Key Trial Results at LINC 2024
Mar 06
7:01am ET
InspireMD reports Q4 EPS (16c) vs (60c) last year
Feb 12
7:06am ET
InspireMD appoints principal investigators for C-GUARDIANS II clinical trial
Jan 31
7:05am ET
InspireMD receives CE Mark recertification under E.U.’s new MDR framework
Jan 03
7:18am ET
InspireMD appoints Pete Ligotti as EVP, GM of North America
No recent press releases are available for NSPR
NSPR Financials
Key terms
Ad Feedback
NSPR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NSPR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range